Related Experiment Video
Updated: Feb 7, 2026

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
Published on: October 24, 2015
Diosgenin inhibited the expression of TAZ in hepatocellular carcinoma
Zhize Chen1, Jingjing Xu1, Yang Wu1
1Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei, People's Republic of China.
Abstract:
Emerging evidence has supported that TAZ (transcriptional co-activator with PDZ binding motif), one transcription co-activator in Hippo signaling pathway, plays an oncogenic role in liver carcinogenesis. Targeting TAZ could be a potential therapeutic approach for liver cancer patients. In the current study, we aim to determine whether diosgenin could be an inhibitor of TAZ in liver cancer cells. We found that diosgenin inhibited the expression of TAZ in liver cancer cells. Moreover, we found that diosgenin inhibited cell growth, induced apoptosis, suppressed cell migration and invasion in part via inhibition of TAZ in liver cancer cells. Our study provides the evidence to support that diosgenin could be a potential agent for treating human liver cancer.
Insights
Diosgenin inhibits the oncogenic TAZ protein in liver cancer cells. This natural compound suppressed cancer growth, promoted cell death, and reduced metastasis, offering a potential new treatment for liver cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- The Hippo signaling pathway regulates organ size and is crucial in cancer development.
- TAZ (transcriptional co-activator with PDZ binding motif) is a key component of the Hippo pathway implicated in liver carcinogenesis.
- Targeting TAZ presents a promising therapeutic strategy for liver cancer.
Purpose of the Study:
- To investigate the potential of diosgenin as an inhibitor of TAZ in liver cancer cells.
- To elucidate the mechanisms by which diosgenin affects liver cancer progression.
Main Methods:
- In vitro studies using liver cancer cell lines.
- Assessment of TAZ expression levels.
- Evaluation of cell proliferation, apoptosis, migration, and invasion assays.
Main Results:
- Diosgenin significantly inhibited TAZ expression in liver cancer cells.
- Diosgenin suppressed cancer cell proliferation and induced apoptosis.
- Diosgenin reduced the migration and invasion capabilities of liver cancer cells, partly through TAZ inhibition.
Conclusions:
- Diosgenin demonstrates potent anti-cancer effects in liver cancer models.
- Inhibition of TAZ by diosgenin is a key mechanism underlying its therapeutic potential.
- Diosgenin represents a promising natural agent for the treatment of human liver cancer.
Related Concept Videos
Feedback Inhibition
What is Gene Expression?
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...
Enzyme Inhibition
Chromatin Position Affects Gene Expression
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
Inhibition of Cdk Activity
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...

